It can cause uncomfortable symptoms like fatigue and in severe cases, can lead to heart failure. Abbott’s device, called the MitraClip, works by clipping the mitral valve’s leaflets together ...

The system is available for patients whose mitral valves are not working properly due to severe mitral annular calcification.

Abbott (NYSE: ABT) announced today that it received FDA approval for its Tendyne transcatheter mitral valve replacement (TMVR) system.

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Abbott Laboratories is launching a new clinical trial ...

ABBOTT PARK, Ill., March 24, 2025 /PRNewswire/ -- Abbott today announced that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) for its Coronary ...

director of the Center for Valve & Structural Heart Disease for the Minneapolis Heart Institute at Abbott Northwestern Hospital. "Patients with MAC can be very difficult to operate on and many are ...

25) and simultaneously published in Circulation show the Abbott TriClip system reduces heart failure hospitalizations The latest results highlight significant improvements in tricuspid ...

The US Food and Drug Administration has approved Abbott's Tendyne Transcatheter Mitral Valve Replacement (TMVR) system. It is indicated for patients with mitral valve disease caused by ...